0001415889-24-008692.txt : 20240319 0001415889-24-008692.hdr.sgml : 20240319 20240319205006 ACCESSION NUMBER: 0001415889-24-008692 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240319 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dyckerhoff Stefan A CENTRAL INDEX KEY: 0001484394 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41979 FILM NUMBER: 24765993 MAIL ADDRESS: STREET 1: 755 PAGE MILL ROAD, STREET 2: SUITE A-200 CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astera Labs, Inc. CENTRAL INDEX KEY: 0001736297 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 823437062 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2901 TASMAN DR. SUITE 205 CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: 408-242-7319 MAIL ADDRESS: STREET 1: 2901 TASMAN DR. SUITE 205 CITY: SANTA CLARA STATE: CA ZIP: 95054 3 1 form3-03202024_120349.xml X0206 3 2024-03-19 0 0001736297 Astera Labs, Inc. ALAB 0001484394 Dyckerhoff Stefan A 755 PAGE MILL ROAD, SUITE A-200 PALO ALTO CA 94304-1005 true false true false Series A Preferred Stock Common Stock 65 I By Limited Partnership (TF) Series A Preferred Stock Common Stock 65 I By Trust Series A Preferred Stock Common Stock 9672 I By Limited Partnership (SHV) Series B Preferred Stock Common Stock 23827 I By Irrevocable Trust Series B Preferred Stock Common Stock 1010 I By Limited Partnership (TF) Series B Preferred Stock Common Stock 179617 D Series B Preferred Stock Common Stock 1010 I By Trust Series B Preferred Stock Common Stock 14957606 I By Limited Partnership (SHV) Series B Preferred Stock Common Stock 203445 I By SHM Investments, LLC Series C Preferred Stock Common Stock 6568 I By Trust Series C Preferred Stock Common Stock 478056 I By Limited Partnership (SHV) Series C Preferred Stock Common Stock 6568 I By SHM Investments, LLC Series D Preferred Stock Common Stock 8861 I By Limited Partnership (TF) Series D Preferred Stock Common Stock 8860 I By Trust Series D Preferred Stock Common Stock 1316256 I By Limited Partnership (SHV) Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock (collectively, the "Preferred Stock") shall automatically convert into one share of Common Stock on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering. The shares of Preferred Stock have no expiration date. Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Shares held by Sutter Hill Ventures, a California Limited Partnership ("SHV"). The Reporting Person is a managing director and member of the management committee of the general partner of SHV. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Shares held by SHM Investments, LLC ("SHMI"). The Reporting Person is a managing member of SHMI. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. /s/ Kanwalpreet S. Kalra, Attorney-in-Fact 2024-03-19 EX-24 2 ex24-03202024_120349.htm ex24-03202024_120349.htm

POWER OF ATTORNEY


Know all by these presents, that the undersigned hereby authorizes Christopher J. Basso or Kanwalpreet S. Kalra to execute for and on behalf of the undersigned Forms 3, 4, and 5, and any Amendments thereto for Astera Labs Inc. (the "Company"), and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in- fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such a capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.


This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.


In witness whereof, the undersigned has caused this Power of Attorney to be executed as of this 15th day of March, 2024.


/s/ Stefan A. Dyckerhoff